CRIS Current Research Information System

MANFREDI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.663
AS - Asia 17.763
EU - Europa 17.738
SA - Sud America 1.334
AF - Africa 929
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 5
Totale 56.452
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.454
GB - Regno Unito 5.496
CN - Cina 5.259
SG - Singapore 4.775
VN - Vietnam 3.972
IT - Italia 2.432
UA - Ucraina 2.299
DE - Germania 2.289
FR - Francia 1.322
SE - Svezia 1.300
HK - Hong Kong 1.134
RU - Federazione Russa 1.023
IN - India 1.019
BR - Brasile 954
IE - Irlanda 518
JP - Giappone 497
ZA - Sudafrica 360
EE - Estonia 337
KR - Corea 324
NL - Olanda 223
SC - Seychelles 209
AR - Argentina 163
FI - Finlandia 151
CI - Costa d'Avorio 134
CA - Canada 105
ID - Indonesia 100
PH - Filippine 98
TG - Togo 98
TH - Thailandia 97
BD - Bangladesh 76
IQ - Iraq 63
EC - Ecuador 58
MX - Messico 53
TR - Turchia 53
GR - Grecia 52
CH - Svizzera 48
BG - Bulgaria 41
CO - Colombia 41
LB - Libano 37
MY - Malesia 36
PL - Polonia 34
PY - Paraguay 33
AT - Austria 32
JO - Giordania 32
CL - Cile 29
TW - Taiwan 29
SA - Arabia Saudita 28
UZ - Uzbekistan 28
PK - Pakistan 27
BE - Belgio 24
VE - Venezuela 24
MA - Marocco 22
ES - Italia 21
KE - Kenya 19
PE - Perù 19
AU - Australia 18
ET - Etiopia 16
IR - Iran 15
RO - Romania 15
CZ - Repubblica Ceca 14
EG - Egitto 14
TN - Tunisia 12
LT - Lituania 11
JM - Giamaica 10
HU - Ungheria 9
NG - Nigeria 9
NP - Nepal 9
SK - Slovacchia (Repubblica Slovacca) 9
DO - Repubblica Dominicana 8
PS - Palestinian Territory 8
DZ - Algeria 7
KZ - Kazakistan 7
SI - Slovenia 7
BO - Bolivia 6
CR - Costa Rica 6
IL - Israele 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
NI - Nicaragua 5
OM - Oman 5
PT - Portogallo 5
DK - Danimarca 4
EU - Europa 4
HN - Honduras 4
KG - Kirghizistan 4
AO - Angola 3
AZ - Azerbaigian 3
BY - Bielorussia 3
GT - Guatemala 3
HR - Croazia 3
PA - Panama 3
SN - Senegal 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
CG - Congo 2
GH - Ghana 2
KW - Kuwait 2
LK - Sri Lanka 2
Totale 56.403
Salva come PNG Salva come JPEG
Città #
Southend 4.922
Singapore 3.093
Jacksonville 1.675
Fairfield 1.531
Ashburn 1.493
Hong Kong 1.093
Hefei 1.045
Chandler 1.008
Wilmington 942
Princeton 936
Dong Ket 901
Santa Clara 813
Woodbridge 752
San Jose 720
Ho Chi Minh City 682
Seattle 647
Houston 645
Hanoi 585
Boardman 546
Lauterbourg 541
Cambridge 539
Dublin 512
Nanjing 478
Tokyo 463
Ann Arbor 455
Westminster 454
Padova 449
Beijing 397
Bologna 374
Berlin 339
Los Angeles 311
Seoul 291
Mülheim 255
Milan 254
Dallas 239
Saint Petersburg 222
Buffalo 215
Jinan 214
Shenyang 199
Mahé 196
Medford 190
Hebei 148
Nanchang 140
Changsha 138
Helsinki 136
Abidjan 134
The Dalles 133
San Diego 126
Tianjin 117
Verona 114
Haiphong 106
New York 102
Redondo Beach 100
Lomé 98
Rome 97
Des Moines 90
Jiaxing 84
Da Nang 83
Zhengzhou 82
Guangzhou 81
Hangzhou 81
São Paulo 81
Shanghai 75
Phoenix 74
Dearborn 69
Kunming 66
Yubileyny 66
Bengaluru 64
Chicago 61
Bangkok 59
Redmond 59
Norwalk 58
San Francisco 58
Olalla 57
Ningbo 54
Frankfurt am Main 53
Falls Church 52
Lanzhou 46
Haikou 45
London 43
Rio de Janeiro 42
Ingolstadt 39
Jakarta 39
Biên Hòa 38
Wuhan 38
Turin 37
Hải Dương 36
Sofia 36
Bühl 35
Redwood City 35
Taizhou 35
Amman 32
Can Tho 31
Orem 30
Florence 29
Fuzhou 28
Taiyuan 27
Council Bluffs 26
Montreal 26
Shenzhen 26
Totale 35.611
Salva come PNG Salva come JPEG
Nome #
Update on the appropriate use of linezolid in clinical practice 573
Candidosi esofagea ricorrente in corso di infezione da HIV non associata ad evidente stato di immunodeficienza, ed in presenza di un trattamento antiretrovirale efficace 278
The destiny of italian prisoners in austro-hungarian pow camps during the first world war: Remembering the defeat of caporetto 100 years on 259
Assessing the impact of hepatitis C virus coinfection on lopinavir/ritonavir trough concentrations in HIV-infected patients. 242
Acute onset myopericarditis as unusual presentation of primary HIV infection 238
The plague which hit the city of Bologna in the year 1630 232
Turicella otitidis central venous-related bacteremia during pediatric acute lymphoblastic leukemia 224
Ultrastructural liver mitochondrial abnormalities in HIV/HCV-coinfected patients receiving antiretroviral therapy 218
Admission of foreign citizens to the general teaching hospital of Bologna, northeastern Italy: an epidemiological and clinical survey 214
A 2-year survey of bacteriologic profile and antimicrobial susceptibility levels of Enterococci in a large Italian teaching hospital. 213
A decade surveillance study of Mycobacterium xenopi disease and antimicrobial susceptibility levels in a reference teaching hospital of northern Italy: HIV-associated versus non-HIV-associated infection. 210
HIV enteropathy: undescribed ultrastructural changes of duodenal mucosa and their regression after triple antiviral therapy. A case report 203
Cardiovascular risk factors and ultrasound evaluation of carotid atherosclerosis in patients with HIV-1 infection. 198
Dual raltegravir-darunavir/ritonavir combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy including a ritonavir-boosted protease inhibitor plus two nucleoside/nucleotide reverse transcriptase inhibitors 193
Fatal long-term immunosuppressive therapy with uncontrolled repeat prescription 191
Reactivation of severe, acute pulmonary tuberculosis during treatment with pegylated interferon-alpha and ribavirin for chronic HCV hepatitis 191
Paradoxical response to intravenous immunoglobulin in a case of Parvovirus B19-associated chronic fatigue syndrome 190
Causes of hospitalization among Extra-European Union children in a large Hospital of Northern Italy, in a five-year observation period 188
Myocardial infarction risk in HIV-infected patients: epidemiology, pathogenesis, and clinical management 188
Abacavir-induced febrile agranulocytosis and anaemia. 187
Substitution of nevirapine or efavirenz for protease inhibitor versus lipid-lowering therapy for the management of dyslipidaemia. 186
Skeletal muscle toxicity in HIV-1-infected patients treated with a raltegravir-containing antiretroviral therapy: a cohort study. 184
A novel antiretroviral class (fusion inhibitors) in the management of HIV infection. Present features and future perspectives of enfuvirtide (T-20) 183
Diffusa disseminazione cutanea di una leishmaniosi viscerale in corso di infezione da HIV: un percorso diagnostico e terapeutico. 183
Plasma Levels of VCAM-1, ICAM-1, E-Selectin, and P-Selectin in 99 HIV-positive patients versus 51 HIV-negative healthy controls. 182
A prospective evaluation of maraviroc administration in patients with advanced HIV disease and multiple comorbidities: focus on efficacy and tolerability issues 182
Basic clinical-applied pharmacoeconomic features of antiretroviral therapy. A pilot single-centre study performed on around 1000 HIV-infected individuals receiving combined antiretroviral treatment 181
Atypical progressive multifocal leukoencephalopathy in HIV with a high CD4 count: the use of magnetic resonance imaging plus spectrometry studies 181
Prevalence of renal disease within an urban HIV-infected cohort in northern Italy. 181
Management of Strongyloides stercoralis extensive infestation in a patient with Sjogren syndrome 174
Increasing pathomorphism of pulmonary tuberculosis: an observational study of slow clinical, microbiological, and imaging response of lung tuberculosis to specific treatment. Which role for linezolid? 173
A puzzling microbiological and clinical discrepancy in the management of acute, severe skin-soft tissue and joint staphylococcal infection. In vitro antimicrobial susceptibility to glycopeptides, versus in vivo clinical efficacy of linezolid alone 172
Abdominal neoplasia with sarcomatoid features as the presenting illness of a patient with a newly diagnosed HIV infection and no AIDS-related disorders. Case report, clinical and diagnostic features, and literature discussion 172
Chronic hepatitis with diffuse steatosis and slight fibrosis related to etretinate therapy 171
Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management 171
Insulin resistance and diabetes mellitus in HIV-infected patients receiving antiretroviral therapy 171
Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitors: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/mmc) 171
La peste di Giustiniano (prima parte) 171
Protease inhibitor monotherapy as maintenance regimen in patients with HIV infection. 171
No correlation between statin exposure and incident diabetes mellitus in HIV-1-infected patients receiving combination antiretroviral therapy 169
Cytokine storm in aged people with CoV-2: possible role of vitamins as therapy or preventive strategy 169
Pancreotoxicity of propofol sedation during purulent meningitis. 168
Measles outbreak in the city of Bologna, December 2007 to May 2008 168
Two-Year Treatment with Rosuvastatin Reduces Carotid Intima-Media Thickness in HIV Type 1-Infected Patients Receiving Highly Active Antiretroviral Therapy with Asymptomatic Atherosclerosis and Moderate Cardiovascular Risk. 167
Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDS 167
Gynecomastia, lipodystrophy syndrome, and dyslipidemia occurring or worsening during antiretroviral regimens other than protease inhibitor-based ones. 166
A prospective comparison of hepatotoxicity of the two currently available non-nucleoside reverse transcriptase inhibitors in a homogeneous case-mix of HIV-infected patients treated for the first time with efavirenz or nevirapine, according to their different baseline conditions 165
Bone mass loss in patients with human immunodeficiency virus type 1 infection: association with male sex and protease inhibitor therapy 164
A very particular case of long-term non-progressor: nineteen consecutive years of follow-up in the absence of any detectable HIV-1 viraemia 164
Plasma concentrations of efavirenz, darunavir/ritonavir and raltegravir in HIV-HCV-coinfected patients without liver cirrhosis in comparison with HIV-monoinfected patients. 164
Abacavir-lamivudina versus tenofovir-emtricitabina più atazanavir-ritonavir nella semplificazione dell'HAART per dislipidemia 164
Long-term "self-managed" immunosuppressive treatment resulting in death due to fulminant hepatitis B 163
Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy 163
Incidence of renal toxicity in HIV-infected, antiretroviral-naïve patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir, or lopinavir/ritonavir 162
Candida albicans panuveitis and an uneven therapeutic ground, passing through all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole 161
Liposomal amphotericin B and HIV-associated visceral leishmaniasis: concerns about nephrotoxicity and administration schedule 161
Voriconazole proves effective in long-term treatment of a cerebral cryptococcoma in a chronic nephropathic HIV-negative patient, after fluconazole failure 161
Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients. 160
Prospective, open-label comparative study of liver toxicity in an unselected population of HIV-infected patients treated for the first time with efavirenz or nevirapine 160
Rosuvastatin for the treatment of hyperlipidaemia in HIV-infected patients receiving protease inhibitors: a pilot study. 159
Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-alpha in HIV-infected patients treated with ritonavir-boosted protease inhibitors. 159
Efavirenz versus nevirapine in current clinical practice: a prospective, open-label observational study. 158
Georges Canguilhem. Sulla Medicina. Scritti 1955-1989, Einaudi, 2007 158
Severe peripheral neuropathy with areflexic and flaccid quadriplegia complicating Legionnaires’ disease in an adult patient. 158
Methicillin-resistant staphylococci still susceptible to non-beta-lactam antibiotics. What clinical implications in nosocomially-acquired infections? 157
Novel pharmaceutical molecules against emerging resistant gram-positive cocci 157
First-line efavirenz versus lopinavir/ritonavir-based highly active antiretroviral therapy for naïve patients. 156
Legionnaires' disease associated with macular rash: two cases 156
Antibodies reactive with C-terminus of the second conserved region of HIV-1 gp120 as possible prognostic marker and therapeutic agent for HIV disease 156
Membranoproliferative glomerulonephritis associated with human immunodeficiency virus, hepatitis B and hepatitis C virus coinfection: case report and literature review. 155
Loss of bone mass in chronically HIV-infected patients. Significant association with male gender and protease inhibitor administration 155
Aggressive, metastatic squamous cell carcinoma after a 46-year-old history of chronic osteomyelitis and local infectious complications: a case report 155
Polyunsaturated ethyl esters on n-3 fatty acids in HIV-infected patients with moderate hypertriglyceridemia: comparison with dietary and lifestyle changes, and fibrate therapy. 154
Neurosyphilis in a young adult: very early tertiary syphilis? 154
Efficacy and tolerability of a fosamprenavir-ritonavir-based versus a lopinavir-ritonavir-based antiretroviral treatment in 82 therapy-naïve patients with HIV-1 infection. 154
An observational study of subcutaneous multiple lipomatosis in patients receiving highly active antiretroviral therapy. Possible correlations with metabolic abnormalities and pathogenetic insights 153
Antiretroviral therapy voluntarily taken at half-dosage, but fully effective after 6-10 years: a provocative issue for adherence requirements. Case report 153
Primary Cytomegalovirus infection in otherwise healthy adults with Fever of Unknown Origin: a 3-year prospective survey 152
Severe Community - Acquired Achromobacter denitrificans Cellulitis 151
Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy. 151
Aderenza alla terapia antiretrovirale "autogestita" dai pazienti alla metà della posologia giornaliera raccomandata. Inattesa efficacia immunologica e virologica a lungo termine 151
Lopinavir/ritonavir trough concentrations with the tablet formulation in HIV-1-infected women during the third trimester of pregnancy. 151
A patient with a 12-year history characterized by four non-AIDS-related malignancies, occurring before and after the disclosure of HIV infection 149
Community-acquired pneumonia and sepsis caused by a multiresistant Staphylococcus aureus strain resulting in a severe and long-lasting multiple organ inflammatory involvement 148
Tuberculosis in a metropolitan area of northern Italy: epidemiological trends and public health concerns 146
Antiretroviral treatment and gynecomastia: which correlations? 145
Changing epidemiology of hepatitis A in the Bologna metropolitan area, northern Italy: importance of counselling and prophylactic measures for the male homo/bisexual population. 145
Bladder carcinoma and HIV infection during the highly active antiretroviral therapy era: a rare, but intriguing association. Two case reports and literature review 145
Comparison between switching therapy from protease inhibitors to an NNRTI and lipid-lowering therapy with pravastatin or bezafibratef for the management of HAART-related dyslipidemia 144
Diffuse skin spread of HIV-associated visceral leishmaniasis: cumbersome diagnostic and therapeutic issues 144
Multiple, severe lung infiltrates due to Mycobacterium avium-intracellulare in a patient with decompensated liver cirrhosis: spontaneous resolution after a two-year follow-up 144
Epidemiological, clinical and therapeutic features of AIDS-related Mycobacterium kansasii infection during the HIV pandemic: an 11-year follow-up study. 144
Safety issues about nevirapine administration in HIV-infected pregnant women 143
Tubercular disease caused by Bacillus of Calmette-Guérin as a local adjuvant treatment of relapsing bladder carcinoma 143
In vitro antimicrobial sensitivity trends of Enterococci isolated at an Italian teaching hospital. A 2004-2007 prospective report including over 2,700 examined microbial strains 143
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors 143
Diffuse cutaneous dissemination of visceral leishmaniasis during human immunodeficiency virus (HIV) infection, despite negligible immunodeficiency: repeated failure of liposomal amphotericin B administration, followed by successful long-term pentamidine and paromomycin administration 143
Rosuvastatin and atorvastatin preserve renal function in HIV-1-infected patients with chronic kidney disease and hyperlipidaemia 143
A young patient with perinatal HIV infection treated for 17 consecutive years with antiretroviral therapy: extremely severe lipo-accumulation picture 143
Coinfection with HIV and hepatitis C virus and immune restoration during HAART 142
Totale 17.436
Salva come PNG Salva come JPEG
Categoria #
all - tutte 152.994
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 152.994
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.980 0 0 0 0 0 0 0 0 0 0 354 1.626
2021/20226.973 780 380 439 685 645 477 116 468 216 347 1.170 1.250
2022/20235.626 735 882 352 681 343 328 191 269 937 160 580 168
2023/20241.201 100 241 101 101 87 159 82 71 43 111 51 54
2024/20257.001 155 1.576 763 521 1.444 314 394 105 79 253 96 1.301
2025/202615.673 815 1.663 2.162 1.606 1.936 1.094 1.216 537 2.737 1.493 414 0
Totale 57.316